Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory
Karyopharm Therapeutics Angeforderte Firma
Karyopharm is an innovation-driven pharmaceutical company whose core technology leverages the inhibition of nuclear export as a mechanism to treat patients with cancer and other medical conditions Weiterlesen
Overall it’s been somewhat positive despite some bumps in the road. My immediate team is the best things about the jo
Was gefällt dir am besten am Führungsteam?
Focused on patients first & customer engagement
Warum fühlen Sie sich unterbewertet und was würde Sie bei Ihrer Vergütung besser fühlen lassen?
Bonus structure needs to be re-evaluated
Was sind einige der besten Dinge an Ihrem Team?
Supportive of wins & fun
Was ist am positivsten an Kultur und Umgang in Ihrem Unternehmen?
Transparent and will reward success
Was macht Sie bei der Arbeit am glücklichsten?
Positive interactions with customers (selling)
Other Employee Reviews for Karyopharm Therapeutics
×